TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ORMP

Oramed Pharmaceuticals Inc

Healthcare · Biotechnology

4.70$ +1.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Oramed Pharmaceuticals Inc (ORMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 231 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORMP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
22 26 43 39 47 35 45 128 162 221 155 231
22 17 31 20 31 33 41 95 157 163 143 133
1.8 3.2 3.9 4.0 5.0 3.3 19 77 40 9.1 54 46
21 17 31 20 30 32 40 94 156 162 142 126
0.4 4.6
0.0
1.0 1.5 17 19 16 15 12 11 10 58 9.9 31
1.0 1.5 3.6 5.2 4.6 5.3 4.5 6.7 5.7 53 5.7 19
0.0 0.1 0.2 51 0.2 0.3
0.9 1.0 1.4 0.6 1.1 1.3 0.6 2.6 2.2 0.6 0.8 0.4
21 25 26 19 31 19 33 116 152 164 146 200
-28 -35 -46 -56 -69 -81 -93 -115 -163 -158 -177 -123
9.2 11 13 13 15 17 21 28 39 41 41 42

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?